United States - English - NLM (National Library of Medicine)

mwi/vetone - nitrofurazone (unii: x8xi70b5z6) (nitrofurazone - unii:x8xi70b5z6) - nitrofurazone 0.9072 g in 454 g - ​ ​nitrofurazone (0.2% nitrofurazone in a water-soluble base) ​ointment ​antibacterial preparation for topical application for use only on dogs, cats and horses (not for food use). keep out of reach of children. ​caution: ​federal law prohibits the use of this product in food-producing animals. nada 140-851, approved by fda

United States - English - NLM (National Library of Medicine)

dechra veterinary products - trilostane (unii: l0fpv48q5r) (trilostane - unii:l0fpv48q5r) - trilostane 5 mg - vetoryl capsules are indicated for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. the use of vetoryl capsules is contraindicated in dogs that have demonstrated hypersensitivity to trilostane. do not use vetoryl capsules in animals with primary hepatic disease or renal insufficiency (see warnings and precautions ). do not use in pregnant dogs. studies conducted with trilostane in laboratory animals have shown teratogenic effects and early pregnancy loss.

United States - English - NLM (National Library of Medicine)

mwi/vetone - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d), clorsulon (unii: eg1zdo6lrd) (clorsulon - unii:eg1zdo6lrd) - ivermectin 10 mg in 1 ml - vetrimectm plus injection is indicated for the effective treatment and control of the following parasites in cattle: gastrointestinal roundworms (adults and fourth-stage larvae): ostertagia ostertagi (including inhibited o. ostertagi ) o. lyrata haemonchus placei trichostrongylus axei t. colubriformis cooperia oncophora c. punctata c. pectinata bunostomum phlebotomum nematodirus helvetianus (adults only) n. spathiger (adults only) oesophagostomum radiatum lungworms (adults and fourth-stage larvae): dictyocaulus viviparus liver flukes: fasciola hepatica (adults only) cattle grubs (parasitic stages): hypoderma bovis h. lineatum sucking lice: linognathus vituli haematopinus eurysternus solenopotes capillatus mange mites (cattle scab*): psoroptes ovis (syn. p. communis var. bovis ) sarcoptes scabiei var. bovis ivermectin and clorsulon injection has been proved to effectively control infections and to protect cattle from reinfection with dictyocaulus viviparus and oesophagostomum radiatum for 28 days

New Zealand - English - Ministry for Primary Industries

veto-pharma s.a.s. - amitraz - amitraz 33 g/kg - miticide

Israel - English - Ministry of Health

unipharm trading ltd, israel - everolimus - tablets - everolimus 10 mg - everolimus - evetor is indicated for:- treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. the effectiveness of evetor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease. the safety and effectiveness of evetor in the treatment of patients with carcinoid tumors have not been established. - treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes. - treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.

Israel - English - Ministry of Health

unipharm trading ltd, israel - everolimus - tablets - everolimus 2.5 mg - everolimus - evetor is indicated for:- treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. the effectiveness of evetor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease. the safety and effectiveness of evetor in the treatment of patients with carcinoid tumors have not been established. - treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes. - treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.

Israel - English - Ministry of Health

unipharm trading ltd, israel - everolimus - tablets - everolimus 5 mg - everolimus - evetor is indicated for:- treatment of patients with sega associated with tuberous sclerosis complex (tsc) who require therapeutic intervention but are not candidates for curative surgical resection. the effectiveness of evetor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated. - treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease. the safety and effectiveness of evetor in the treatment of patients with carcinoid tumors have not been established. - treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non – steroidal aromatase inhibitor. - treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (tsc), not requiring immediate surgery. the effectiveness of evetor in treatment of renal angiomyolipoma is based on an analysis of durable objective responses in patients treated for a median of 8.3 months. further follow-up of patients is required to determine long-term outcomes. - treatment of patients with advanced renal cell carcinoma, whose disease has progressed on or after treatment with vegf-targeted therapy.- treatment of unresectable, locally advanced or metastatic, well-differentiated (grade 1 or grade 2) non-functional neuroendocrine tumours of gastrointestinal or lung origin in adults with progressive disease.

United States - English - NLM (National Library of Medicine)

mwi/vetone - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 10 mg in 1 ml - cattle: vetrimec™ 1 % injection is indicated for the effective treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, grubs, sucking lice, and mange mites in cattle: gastrointestinal roundworms (adults and fourth-stage larvae): ostertagia ostertagi (including inhibited o. ostertagi) o. lyrata haemonchus placei trichostrongylus axei t. colubriformis cooperia oncophora c. punctata c. pectinata oesophagostomum radiatum bunostomum phlebotomum nematodirus helvetianus (adults only) n. spathiger (adults only) lungworms (adults and fourth-stage larvae): dictyocaulus viviparus cattle grubs (parasitic stages): hypoderma bovis h. lineatum sucking lice: linognathus vituli haematopinus eurysternus solenopotes capillatus mites (scabies): psoroptes ovis (syn. p. communis var. bovis) sarcoptes scabiei var. bovis ivermectin injection has been proved to effectively control infections and to protect cattle from reinfection with dictyocaulus viviparus and oesophagostomum radi

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - trilostane - capsule, hard - 30 milligrams per capsule - trilostane

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - trilostane - capsule, hard - 60 milligrams per capsule - trilostane